Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
In order to compare the clinical and microbiological efficacies and safety of piperacillin plus tazobactam with those of imipenem plus cilastatin, 134 patients with intra-abdominal infections (73 patients with appendicitis) participated in an open randomized comparative multicenter trial. A total of...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1992
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245542/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1336347/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2766 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
